Newsletter Subscription

The Role of Gemcitabine in the Treatment of Pancreatic Cancer

First Issue: The Role of Gemcitabine in the Treatment of Pancreatic Cancer

Newsletter Details:

Pancreatic cancer is the fourth most common malignancy and the fourth leading cause of cancer-related death in the US. Patients with early-stage pancreatic carcinoma are typically treated using surgery, adjuvant chemotherapy or chemoradiation, or combinations of these modalities. Surgical resection offers the only chance of real cure; however, less than 20% of patients with pancreatic cancer are candidates for surgery because the disease is usually detected only in its later stages.

STEP 1: Create An Account
  • 6+ Letters/Numbers

About Dynamic Seminars & Consulting, Inc.

DSC has been educating the healthcare industry since 1997. We have continued to provide and present the most dynamic and informative sales and marketing programs for a long list of healthcare professionals. When the Health Insurance Association of America sought customer service training for this leading US industry, they turned to Louis Feuer, MA, MSW, founder of Dynamic Seminars... Read More

About PRIME Education, Inc.

PRIME® is a full-service ACCME Exemplary Accredited provider of innovative CME and CE via program concept, design, development, accreditation and delivery in multimedia venues throughout the health care industry and state and federal governments. Serving the acute, community and long term care healthcare industries since 1994, PRIME® has worked for, consulted for and partnered with... Read More